Transce3nd, LLC Vaxart, Inc. Transaction History
Transce3nd, LLC
- $295 Billion
- Q4 2024
A detailed history of Transce3nd, LLC transactions in Vaxart, Inc. stock. As of the latest transaction made, Transce3nd, LLC holds 235 shares of VXRT stock, worth $176. This represents 0.0% of its overall portfolio holdings.
Number of Shares
235Holding current value
$176% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VXRT
# of Institutions
102Shares Held
36.3MCall Options Held
83.6KPut Options Held
160K-
Sio Capital Management, LLC New York, NY11.5MShares$8.64 Million2.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$7.56 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.99MShares$2.24 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.6MShares$1.95 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.77MShares$1.33 Million0.0% of portfolio
About Vaxart, Inc.
- Ticker VXRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,506,000
- Market Cap $94.9M
- Description
- Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...